Cardiac ischemia is a medical condition characterized by a reduction in blood flow to the heart muscle, typically resulting from the narrowing or blockage of coronary arteries. This diminished blood supply deprives the heart tissue of vital oxygen and nutrients, potentially causing damage or the death of affected cells. The consequences of cardiac ischemia extend to the development of various heart-related issues, including angina and myocardial infarction (heart attack). Recognizable symptoms encompass chest pain or discomfort, shortness of breath, and fatigue. Prompt diagnosis and intervention are essential to effectively manage cardiac ischemia, preventing more severe complications and promoting overall heart health. Treatment approaches may involve lifestyle modifications, medications, and, when necessary, medical procedures tailored to address and alleviate the impacts of cardiac ischemia. Regular monitoring and close collaboration with healthcare professionals play a pivotal role in the successful management of this condition.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Preservation of Skeletal Muscle Mass During GLP 1 Receptor Agonist Mediated Weight Loss Clinical Determinants Risk Stratification and Evidence Based Mitigation Strategies
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : A Unique Case of Infective Endocarditis: Staphylococcus lugdunensis Infective Endocarditis Presenting as Embolic Occipital Stroke Due to Posterior Mitral Leaflet Perforation
Nuha Hasnain, Royal Preston Hospital, United Kingdom
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation